PTN Projected Dividend Yield
Palatin Technologies Inc ( AMEX : PTN )Palatin Technologies is a biopharmaceutical company developing medicines based on molecules that modulate the activity of the melanocortin receptor systems. Co.'s product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. Co.'s U.S. Food and Drug Administration approved melanocortin receptor agonist, Vyleesi®, is an as needed therapy used in anticipation of sexual activity and self-administered in the thigh or abdomen via a single-use subcutaneous auto-injector by premenopausal women with hypoactive sexual desire disorder. 20 YEAR PERFORMANCE RESULTS |
PTN Dividend History Detail PTN Dividend News PTN Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |